Table 4 Association of immune cell type proportions with ECTexp and ECTresp (percent or remission).
Percent response | ECTexp | Percent response x ECTexp interaction | |||||||
|---|---|---|---|---|---|---|---|---|---|
Cell type | Estimate | SE | P-value | Estimate | SE | P-value | Estimate | SE | P-value |
NLR | 5.57E-03 | 2.78E-03 | 5.03E-02 | 1.04E-01 | 8.05E-02 | 2.01E-01 | -3.30E-03 | 3.07E-03 | 2.86E-01 |
CD4T | −1.11E-04 | 2.30E-04 | 6.30E-01 | −7.78E-03 | 6.54E-03 | 2.38E-01 | 2.64E-04 | 2.49E-04 | 2.92E-01 |
CD8T | −4.09E-04 | 1.91E-04 | 3.68E-02 | −4.80E-03 | 3.39E-03 | 1.61E-01 | 2.31E-05 | 1.20E-04 | 8.48E-01 |
Neu | 8.66E-04 | 4.31E-04 | 4.96E-02 | 1.82E-02 | 1.25E-02 | 1.48E-01 | -5.15E-04 | 4.74E-04 | 2.82E-01 |
Mono | −9.01E-05 | 1.24E-04 | 4.71E-01 | −6.33E-04 | 2.74E-03 | 8.18E-01 | 1.08E-04 | 1.00E-04 | 2.87E-01 |
Bcell | −1.22E-04 | 8.27E-05 | 1.44E-01 | −3.58E-03 | 1.78E-03 | 4.69E-02 | 8.52E-05 | 6.44E-05 | 1.91E-01 |
NK | −1.26E-04 | 1.05E-04 | 2.39E-01 | −7.28E-04 | 3.30E-03 | 8.26E-01 | 7.38E-05 | 1.28E-04 | 5.65E-01 |
Remission | ECTexp | Remission x ECTexp interaction | |||||||
Cell type | Estimate | SE | P-value | Estimate | SE | P-value | Estimate | SE | P-value |
NLR | 3.86E-01 | 1.26E-01 | 3.36E-03 | 1.03E-01 | 8.04E-02 | 2.04E-01 | −2.26E-01 | 1.55E-01 | 1.48E-01 |
CD4T | −1.08E-02 | 1.08E-02 | 3.21E-01 | −7.79E-03 | 6.54E-03 | 2.37E-01 | 1.68E-02 | 1.25E-02 | 1.86E-01 |
CD8T | −1.81E-02 | 9.19E-03 | 5.34E-02 | −4.79E-03 | 3.39E-03 | 1.61E-01 | 3.44E-03 | 6.08E-03 | 5.74E-01 |
Neu | 6.31E-02 | 1.93E-02 | 1.89E-03 | 1.80E-02 | 1.24E-02 | 1.51E-01 | −3.36E-02 | 2.40E-02 | 1.66E-01 |
Mono | −1.49E-02 | 5.61E-03 | 1.02E-02 | −7.13E-04 | 2.71E-03 | 7.93E-01 | 8.59E-03 | 5.01E-03 | 9.15E-02 |
Bcell | −7.87E-03 | 3.86E-03 | 4.62E-02 | −3.60E-03 | 1.77E-03 | 4.56E-02 | 3.48E-03 | 3.29E-03 | 2.95E-01 |
NK | −1.17E-02 | 4.80E-03 | 1.81E-02 | −7.22E-04 | 3.30E-03 | 8.27E-01 | 3.82E-03 | 6.48E-03 | 5.57E-01 |
